Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database
Drug Safety · 2026-06 · 49 (6) · 689-704
DOI: 10.1007/s40264-026-01648-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Safety, online erschienen am 22.03.2026. Verfasst von Giuseppe Roberto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Università degli Studi di Firenze, Scuola diScienze della Salute Umana, Largo Brambilla, 50134, Florence, Italy. giuseppe.roberto@ars.toscana.it. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Antibodies, Monoclonal, Humanized, Factor Xa, Disseminated Intravascular Coagulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi di Firenze.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Università degli Studi di Firenze, Scuola diScienze della Salute Umana, Largo Brambilla, 50134, Florence, Italy. giuseppe.roberto@ars.toscana.it.
- Department of Emergency Medicine, Careggi University Hospital, Firenze, Italy.
- Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
- Department of Neurosciences, Psychology, Drug Research and Child Health, NEUROFARBA, University of Florence, Florence, Italy.
- Tuscan Regional Centre of Pharmacovigilance, Florence, Italy.
- Azienda Ospedaliera Universitaria di Careggi, Clinical Toxicology and Poison Control Centre, Firenze, Italy.
Förderung
- Università degli Studi di Firenze
Zitieren
APA
Roberto, G., Parmeggiani, L., Flaccavento, A., Vannacci, A., Mannaioni, G., Gini, R., Virgili, G., & Tuccori, M. (2026). Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database. Drug Safety, 49(6), 689-704. https://doi.org/10.1007/s40264-026-01648-8
Vancouver
Roberto G, Parmeggiani L, Flaccavento A, Vannacci A, Mannaioni G, Gini R, et al. Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database. Drug Safety. 2026;49(6):689-704. doi:10.1007/s40264-026-01648-8
BibTeX
@article{Roberto2026,
author = {Roberto, Giuseppe and Parmeggiani, Lorenzo and Flaccavento, Alessandra and Vannacci, Alfredo and Mannaioni, Guido and Gini, Rosa and Virgili, Gianni and Tuccori, Marco},
title = {Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database},
journal = {Drug Safety},
year = {2026},
volume = {49},
number = {6},
pages = {689--704},
doi = {10.1007/s40264-026-01648-8}
}
EUVIMED